Search Results - "SEHY, David"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    A novel microfluidic microplate as the next generation assay platform for enzyme linked immunoassays (ELISA) by Kai, Junhai, Puntambekar, Aniruddha, Santiago, Nelson, Lee, Se Hwan, Sehy, David W, Moore, Victor, Han, Jungyoup, Ahn, Chong H

    Published in Lab on a chip (07-11-2012)
    “…In this work we introduce a novel microfluidic enzyme linked immunoassays (ELISA) microplate as the next generation assay platform for unparalleled assay…”
    Get more information
    Journal Article
  2. 2

    IL-6 Promotes NK Cell Production of IL-17 during Toxoplasmosis by Passos, Sara T, Silver, Jonathan S, O'Hara, Aisling C, Sehy, David, Stumhofer, Jason S, Hunter, Christopher A

    Published in The Journal of immunology (1950) (15-02-2010)
    “…Previous studies have implicated T cell production of IL-17 in resistance to Toxoplasma gondii as well as the development of immune-mediated pathology during…”
    Get full text
    Journal Article
  3. 3

    The in vivo cytokine capture assay for measurement of cytokine production in the mouse by Finkelman, Fred, Morris, Suzanne, Orekhova, Tatyana, Sehy, David

    Published in Current protocols in immunology (01-04-2003)
    “…Because most cytokines are utilized, catabolized, or excreted shortly after they are produced, it has been difficult to directly measure in vivo cytokine…”
    Get more information
    Journal Article
  4. 4

    The inhibitory cytokine IL-35 contributes to regulatory T-cell function by COLLISON, Lauren W, WORKMAN, Creg J, KUO, Timothy T, BOYD, Kelli, YAO WANG, VIGNALI, Kate M, CROSS, Richard, SEHY, David, BLUMBERG, Richard S, VIGNALI, Dario A. A

    Published in Nature (22-11-2007)
    “…Regulatory T (T(reg)) cells are a critical sub-population of CD4+ T cells that are essential for maintaining self tolerance and preventing autoimmunity, for…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Optimiser™ Microplate enables simultaneous multi-analyte quantitation using ultra-low sample volumes in a 2-hour assay: Validation of a Novel 10-Analyte Th17 Cell Panel (124.7) by Kai, Junhai, Moore, Victor, Puntambekar, Aniruddha, Sehy, David, Lakkis, Montaha, Lee, Sean, Han, Jungyoup, Ahn, Chong

    Published in The Journal of immunology (1950) (01-05-2012)
    “…Abstract Optimiser™ Microfluidic ELISA Plates combine microfluidics with 96-well architecture to offer dramatic improvements over conventional ELISA, such as…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Optimiser™ microplate and OptiMax™ reagent systems enable femtogram/ml level sensitivity employing standard ELISA equipment and protocols (65.32) by Kai, Junhai, Santiago, Nelson, Puntambekar, Aniruddha, Lee, Se Hwan, Sehy, David, Durnell, Randy, Schultheis, Ron, Han, Jungyoup, Ahn, Chong

    Published in The Journal of immunology (1950) (01-04-2011)
    “…Abstract Optimiser™ Microfluidic ELISA Plates dramatically enhance ELISA sensitivity through the incorporation of microfluidic channels into a standard ELISA…”
    Get full text
    Journal Article
  10. 10

    Development of functionally active recombinant form of mouse IL-35 (57.11) by Lee, Hyun-Ku, Pascual, David, Sehy, David, Chitta, Sriram, Singh, Gita, Quintel, Payton, Andrew, Kody, Wardle, Lauren, Rosenberg, Jonathan, Singh, Sujay

    Published in The Journal of immunology (1950) (01-04-2011)
    “…Abstract As a novel heterodimeric cytokine and one of the IL-12 family members, IL-35 is composed of IL-12p35 subunit and Epstein-Barr virus-induced gene 3…”
    Get full text
    Journal Article
  11. 11

    IL-6 promotes NK cell production of IL-17 during toxoplasmosis1 by Passos, Sara T., Silver, Jonathan S., O'Hara, Aisling C., Sehy, David, Stumhofer, Jason S., Hunter, Christopher A.

    Published in The Journal of immunology (1950) (18-01-2010)
    “…Previous studies have implicated T cell production of IL-17 in resistance to T. gondii as well as the development of immune mediated pathology during this…”
    Get full text
    Journal Article
  12. 12

    Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-γ and IL-17 secretion by activated human PBMC by Meyers, John A., Mangini, Alyson J., Nagai, Taro, Roff, Calvin F., Sehy, David, van Seventer, Gijs A., van Seventer, Jean Maguire

    Published in Cytokine (Philadelphia, Pa.) (01-09-2006)
    “…Type I interferons (IFN) (IFN-α/β) are recognized as both inhibitors and effectors of autoimmune disease. In multiple sclerosis, IFN-β therapy appears…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Sensitivity of committed hematopoietic progenitor cells in vitro (BFU-E, CFU-E, CFU-GM) and two human carcinoma cell lines toward rhodamine-123 and phosphonium salt II-41 by Sehy, D W, Shao, L E, Rideout, D, Yu, J

    Published in Leukemia research (01-03-1993)
    “…Lipophilic cationic compounds accumulate more rapidly in the mitochondria of many carcinoma-derived cells than in non-transformed cells, thus leading to their…”
    Get more information
    Journal Article